Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2020-09-02 | 2020-09-14 | 123586 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2020-09-02 | 2020-09-14 | 123589 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2020-10-14 | 2020-10-30 | 126320 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2020-12-18 | 2021-04-26 | 130416 |
| APO-VARENICLINE | 0.5MG 1MG | KIT TABLET | Resolved | 2021-02-05 | 2021-03-01 | 133394 |
| APO-VARENICLINE | 1MG | TABLET | Resolved | 2021-02-19 | 2021-02-26 | 134445 |
| APO-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2022-07-29 | 2023-09-01 | 165727 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-09-01 | 2022-11-20 | 168353 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-09-01 | 2022-09-16 | 168356 |
| APO-VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-04-10 | 2018-11-03 | 45353 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-05-31 | 2019-05-31 | 50971 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-12-12 | 2019-03-08 | 69458 |
| APO-VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-12-12 | 2019-12-23 | 69460 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-09 | 2023-01-13 | 177618 |
| APO-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2022-12-16 | 2023-08-18 | 178766 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-04-21 | 2023-09-01 | 189999 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-05-12 | 2023-09-01 | 192361 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-06-09 | 2023-08-18 | 194581 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-04-18 | 2019-05-21 | 82022 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2022-05-16 | 86341 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |